Eplontersen significantly improved patient-reported quality of life following successful research. Positive results from the NEURO-TTRansform phase 3 trial in patients with hereditary transthyretin-mediated amyloid polyneuropathy …

Pre-clinical screening technology could increase cancer test numbers by 50 times. A new screening tool developed at the University of Strathclyde could increase the number …

The joint aim of the companies was to provide vaccines to vulnerable communities. Remote Medical International (RMI) – which specialises in protecting the health of …

The discovery may lead to the development of drugs that halt disease progression and stop memory loss. According to research funded by the British Heart …

WOODSTOCK – OXFORDSHIRE, England, 16th June 2022 – Owen Mumford, a global leader in the design, manufacture and advancement of medical devices today announced that …

SHORT HILLS, NJ. June 16, 2022–(BUSINESS WIRE)– Humanigen, Inc. (Nasdaq: HGEN) (“Humanigen”), a late-stage clinical biopharmaceutical company focused on preventing and treating an immune hyper-response …

The agreement will see the two companies expand current oligonucleotide technologies. Bachem – the Swiss pharmaceutical company – has partnered with Eli Lilly, to further …

New data now reveals significant increases in the blood glucose time-in-range compared to baseline, following VX-880 dosage. Vertex Pharmaceuticals has provided additional data on patients …

Enhertu reduced the risk of disease progression or death compared to chemotherapy in certain patients with metastatic breast cancer. Daiichi Sankyo and AstraZeneca’s breast cancer …

A new facility opens in Cambridge Research Park offering pharmaceutical development services. Pharma and medical device manufacturer, SMC, has announced the opening of Cambridge Pharma …